Your browser doesn't support javascript.
loading
Influence of various assumptions for the individual TNM components on the TNM stage using Nordic cancer registry data.
Engholm, Gerda; Lundberg, Frida E; Kønig, Simon M; Ólafsdóttir, Elínborg; Johannesen, Tom B; Pettersson, David; Mørch, Lina S; Johansson, Anna L V; Friis, Søren.
  • Engholm G; Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society, Copenhagen, Denmark.
  • Lundberg FE; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Kønig SM; Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society, Copenhagen, Denmark.
  • Ólafsdóttir E; Icelandic Cancer Registry, Reykjavik, Iceland.
  • Johannesen TB; Cancer Registry of Norway, Oslo, Norway.
  • Pettersson D; Swedish Cancer Registry, National Board of Health and Welfare, Stockholm, Sweden.
  • Mørch LS; Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society, Copenhagen, Denmark.
  • Johansson ALV; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Friis S; Cancer Registry of Norway, Oslo, Norway.
Acta Oncol ; 62(3): 215-222, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36961761
ABSTRACT

BACKGROUND:

The stage at diagnosis is one of the most important predictors for cancer survival. TNM stage is constructed from T (tumor size), N (nodal spread), and M (distant metastasis) components. In many notifications to cancer registries, TNM information is incomplete with unknown N and/or M. We aimed to evaluate the influence of various assumptions for recoding missing N (NX) and M (MX) as N0 and M0 on the proportion with available TNM stage, stage-distribution, and stage-specific relative survival. MATERIAL AND

METHODS:

We identified 140,201 patients diagnosed with incident cancer of the colon, rectum, lung, breast, or kidney during 2014-2016 in Denmark, Norway, Sweden, or Iceland. Information on TNM were obtained from cancer registry records used for an update of the Nordic cancer statistics database NORDCAN. Patients were followed for death or emigration through 2017. We calculated proportions of available TNM stage, stage distribution, and stage-specific relative survival under different approaches for each cancer site and country.

RESULTS:

Application of the assumptions yielded higher numbers of cases with available TNM stage for stages 0-I, II, and III. We observed only minor differences in stage-specific one-year relative survival when applying N0M0 for missing N and M, especially for high completeness of TNM registrations, whereas relative survival for remaining cases with missing TNM stage declined substantially.

CONCLUSION:

We found no major changes in stage-specific one-year relative survival applying N0M0 for NXMX. We conclude that complete TNM information is preferable to making assumptions, but it seems reasonable to consider assuming N0M0 for missing N and M in future studies based on the Nordic cancer registries. An automatic algorithm, though, is not recommended without considering potential area-specific reasons for frequent use of NX and MX. Clinicians should be urged to report complete TNM information to improve surveillance of the TNM stage.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Datos de Salud Recolectados Rutinariamente / Neoplasias Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Datos de Salud Recolectados Rutinariamente / Neoplasias Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article